Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 576

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer

de Sousa Cavalcante, Lucas, Monteiro, Gisele·2014·European Journal of Pharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejphar.2014.07.041

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 93 references

Research works printed but not linked: 13

  1. Berger, 2013, Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma, Onkologie, 36, 763, 10.1159/000356811 · doi:10.1159/000356811
  2. Bergman, 2000, Cross-resistance in the 2′,2′-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs, Eur. J. Cancer, 36, 1974, 10.1016/S0959-8049(00)00246-X · doi:10.1016/s0959-8049(00)00246-x
  3. Eda, 1998, The antiproliferative activity of DMDC is modulated by inhibition of cytidine deaminase, Cancer Res., 58, 1165
  4. Hatzis, 1998, The intracellular localization of deoxycytidine kinase, J. Biol. Chem., 273, 30239, 10.1074/jbc.273.46.30239 · doi:10.1074/jbc.273.46.30239
  5. Hu, 2011, UMP/CMPK is not the critical enzyme in the metabolism of pyrimidine ribonucleotide and activation of deoxycytidine analogs in human RKO cells, PLoS One, 6, e19490, 10.1371/journal.pone.0019490 · doi:10.1371/journal.pone.0019490
  6. Kim, 2011, The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1, Mol. Cancer, 10, 98, 10.1186/1476-4598-10-98 · doi:10.1186/1476-4598-10-98
  7. Legarza, 2006, New molecular mechanisms of action of camptothecin-type drugs, Anticancer Res., 26, 3301
  8. Mazzon, 2003, Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy, Biochem. Pharmacol., 66, 471, 10.1016/S0006-2952(03)00290-9 · doi:10.1016/s0006-2952(03)00290-9
  9. Portal, 2014, Sustained response with gemcitabine plus nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategy, Clin. Res. Hepatol. Gastroenterol., 38, e23, 10.1016/j.clinre.2014.01.005 · doi:10.1016/j.clinre.2014.01.005
  10. Ritzel, 2001, Mol. Membr. Biol., 18, 65, 10.1080/09687680010026313 · DOI
  11. Sarup, 1989, Regulation of purine deoxynucleoside phosphorylation by deoxycytidine kinase from human leukemic blast cells, Biochem. Pharmacol., 38, 2601, 10.1016/0006-2952(89)90544-3 · doi:10.1016/0006-2952(89)90544-3
  12. Watanabe, 2012, HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines, Cancer Lett., 315, 18, 10.1016/j.canlet.2011.10.005 · doi:10.1016/j.canlet.2011.10.005
  13. Xu, 1992, Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2′,2′-difluorodeoxycytidine, Biochem. Pharmacol., 44, 1819, 10.1016/0006-2952(92)90077-V · doi:10.1016/0006-2952(92)90077-v

Cited by

See all 576

Metadata

Authors
de Sousa Cavalcante, L., & Monteiro, G.
Venue
European Journal of Pharmacology
Publisher
Elsevier BV
Published
2014-10
Volume
741
Pages
8-16
ISSN
0014-2999 (ISSN-L)
OpenAlex
W2045246542
Cited by
576
References
93
FWCI
12.78
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2009/01303-1, 2011/04938-8)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. https://app.cochat.ai/papers/10.1016/j.ejphar.2014.07.041
The paper
de Sousa Cavalcante, L., & Monteiro, G. (2014). Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2014.07.041

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.